CIK 0001806952
- Non-accelerated filer
- Smaller reporting company
Lyell Immunopharma, Inc.
Sign in to watch- Ticker
- LYEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 833006753
- Phone
- +1 650-695-0677
- Business address
- 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale Chief Financial Officer sold 1,453 shares at $10.54 ($15,320)
- 4 Open-market sale Chief Scientific Officer sold 1,453 shares at $10.54 ($15,320)
- 4 Open-market sale President and CEO sold 797 shares at an average $10.43 ($8,313)
- 4 Open-market sale Chief Operating Officer sold 185 shares at an average $10.43 ($1,930)
- 4 Open-market sale Chief Scientific Officer sold 267 shares at an average $10.43 ($2,785)
- 4 Open-market sale Chief Financial Officer sold 267 shares at an average $10.43 ($2,785)
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Medical Officer acquired 21,900 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 9 · 173 filings